Back to search

Article

CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular Dystrophy

2023-04-19

Abstract excerpt

Duchenne muscular dystrophy (DMD) is a lethal neuromuscular disorder caused by loss of dystrophin. Upregulation of utrophin (UTRN), a dystrophin paralogue, is a promising therapeutic avenue. Here, we present a CRISPR-Cas9-mediated strategy to increase utrophin expression by disrupting microRNA (miR) binding sites (BS). Using a Cas9/gRNA ribonucleoprotein (RNP) complex we disrupted several miR BS in DMD myoblasts a...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f8b5a652-8948-5389-b881-074b9c71e6bf
DOI
10.1101/2023.04.18.536394
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRISPR-Cas9 mediated endogenous utrophin upregulation improves Duchenne Muscular DystrophyDOI 10.1101/2023.04.18.536394
Select a neighboring publication to make it the new centre.